RIGL Financial Facts
Total costs and expenses: 25.71MGeneral and administrative: 5.4M
See Full Income Statement
Cash and cash equivalents: 34.16M
Other assets: 1.7M
See Full Balance Sheet
Earnings History for Rigel Pharmaceuticals, Inc. (RIGL)
|
Expand Research on RIGL
| Next EPS Date | 8/6/13 *Est. | EPS Growth Rate | +9.4% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +0.7% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -2.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/7/12  |
Q212 | -$0.35 | -$0.35 | $0.00 | $1.15M | $550K | N/A / N/A | N/A | -65% | Details | |
| 3/5/12 | Q411 | -$0.36 | -$0.28 | -$0.08 | N/A | $2.23M | N/A / N/A | N/A | -61.2% | Details | |
| 5/3/11 | Q111 | -$0.40 | -$0.36 | -$0.04 | N/A | $630K | N/A / N/A | N/A | -58.6% | Details | |
| 11/6/12 |
Q312 | -$0.36 | -$0.37 | +$0.01 | N/A | $750K | N/A / N/A | N/A | -56.3% | Details | |
| 8/2/11 | Q211 | -$0.37 | -$0.38 | +$0.01 | $395K | $420K | N/A / N/A | N/A | -55.9% | Details | |
| 11/2/10 |
Q310 | $0.96 | $0.62 | +$0.34 | N/A | N/A | N/A / N/A | N/A | -53.3% | Details | |
| 11/1/11 |
Q311 | -$0.25 | N/A | N/A | $4.35M | $72.28K | N/A / N/A | N/A | -52% | Details | |
| 5/1/12 |
Q112 | -$0.32 | -$0.31 | -$0.01 | $750K | $620K | N/A / N/A | N/A | -51.2% | Details |
